Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-12-11
2007-12-11
Goldberg, Jeanine A. (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
10741601
ABSTRACT:
The present invention is based on the discovery of genetic polymorphisms that are associated with coronary stenosis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
REFERENCES:
patent: 2003/0092019 (2003-05-01), Meyer et al.
patent: 09 238688 (1997-09-01), None
patent: WO 00/06769 (2000-02-01), None
patent: WO 01/62796 (2001-08-01), None
patent: WO 2004/029243 (2004-04-01), None
Avakian et al. (Clinical Genetics, vol. 60, pp. 381-384, 2001).
Hirschhorn et al. (Genetcs in Medicine. vol. 4, No. 2, pp. 45-61, Mar. 2002).
Ioannidis (Nature Genetics, vol. 29, pp. 306-309, Nov. 2001).
Chowdhary et al. (Cytogenet Cell Genet, vol. 71, pp. 120-123, 1995).
Niemeier, A. et al., “Identification of Megalin/gp330 as a Receptor for Lipoprotein(a) In Vitro,” Arterisclerosis, Thrombosis, and Vascular Biology, vol. 19, Mar. 1999, pp. 552-561.
Willnow, T. et al., “Low Density Lipoprotein Receptor-related Protein and gp330 Bind Similar Ligands, Including Plasminogen Activator-Inhibitor Complexes and Lactoferrin, an Inhibitor of Chylomicron Remnant Clearance,” The Journal of Biological Chemistry, vol. 267 No. 36, Dec. 1992, pp. 26172-26180.
Zou, Z. et al., “Linking Receptor-mediated Endocytosis and Cell Signaling,” The Journal of Biological Chemistry, vol. 279 No. 33, Aug. 2004, pp. 34302-34310.
Wiedmer et al. Identification of three new members of the phospholipids scramblase gene family. Biochimica et Biophysica Acta, vol. 1467, pp. 244-253, 2000.
International Search Report dated Feb. 9, 2005.
Olivieri, Q. et al., “Genetic Polymorphisms of the Renin-Angiotensin System and Atheromatous Renal Artery Gtenosis”, Hypertension, Baltimore, MD, US, vol. 34, No. 5, Nov. 1999, pp. 1097-1100.
Szalai, C. et. al., “Involvement of Polymorphisms in the Chemokine System to the Susceptibility for Coronary Heart Disease (CAD). Coincidence of Elevated Lp(a) and MCP-1 -2518 G/G Genolype in CAD Patients”, Atherosclerosis, vol. 158, No. 1, Sep. 2001, pp. 233-239.
Valdes, A. M., et al., “ValG4,lle Polymorphism in the C-C Chemokine Receptor 2 is Associated with Reduced Coronary Artery Calcification”, Artertosclerosis Thrombosis and Vascular Biology, vol. 22, No. 11, Nov. 2002, pp. 1924-1928.
Veovoda, M. I., et al., “Association of Chemokine Receptor CCR2 Polymorphism with Myocardial Infarction”, Database Biosis [Online] Bioscience Information Service, Philadelphia, PA, US, Jul. 2002, XP002301593 Database Accession No. PREV200300269994.
Weidmer, T. et al., “Identification of Three New Members of the Phospholipid Scramblase Gene Family”, Biochimica et Biophysica Acta, La Jolla, CA, US, vol. 1467, 2000, pp. 244-253.
European Patent Office Communication Pursuant to Article 96(2) EPC, dated Sep. 3, 2007.
Devlin James J.
Luke May M.
Applera Corporation
Goldberg Jeanine A.
Lee Victor K.
Wang Ben
LandOfFree
Genetic polymorphisms associated with coronary stenosis,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic polymorphisms associated with coronary stenosis,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic polymorphisms associated with coronary stenosis,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3847475